[{"address1": "201 Haskins Way", "address2": "Suite 230", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650-407-2376", "website": "https://www.cero.bio", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Daniel Mark Corey M.D.", "title": "Chief Technical Officer", "exercisedValue": 0, "unexercisedValue": 0}], "maxAge": 86400, "priceHint": 4, "previousClose": 3.95, "open": 3.33, "dayLow": 2.81, "dayHigh": 3.45, "regularMarketPreviousClose": 3.95, "regularMarketOpen": 3.33, "regularMarketDayLow": 2.81, "regularMarketDayHigh": 3.45, "beta": -0.384, "volume": 1256614, "regularMarketVolume": 1256614, "averageVolume": 521236, "averageVolume10days": 3042650, "averageDailyVolume10Day": 3042650, "bid": 2.63, "ask": 2.68, "bidSize": 2900, "askSize": 900, "marketCap": 34596420, "fiftyTwoWeekLow": 2.24, "fiftyTwoWeekHigh": 12.8, "fiftyDayAverage": 7.78564, "twoHundredDayAverage": 10.09772, "currency": "USD", "enterpriseValue": 19389986, "floatShares": 5417960, "sharesOutstanding": 11929800, "sharesShort": 12092, "dateShortInterest": 1709164800, "sharesPercentSharesOut": 0.00029999999, "heldPercentInsiders": 0.14811, "heldPercentInstitutions": 0.055970002, "shortRatio": 0.05, "impliedSharesOutstanding": 11929800, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -2516148, "52WeekChange": -0.7284644, "SandP52WeekChange": 0.30583346, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "CERO", "underlyingSymbol": "CERO", "shortName": "CERo Therapeutics Holdings, Inc", "longName": "CERo Therapeutics Holdings, Inc.", "firstTradeDateEpochUtc": 1638282600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "c96e7212-658f-3054-8625-d2aafea7c5eb", "messageBoardId": "finmb_1673740339", "gmtOffSetMilliseconds": -14400000, "currentPrice": 2.9, "recommendationKey": "none", "totalCash": 119014, "totalCashPerShare": 0.019, "totalDebt": 1395000, "quickRatio": 0.025, "currentRatio": 1.764, "returnOnAssets": -0.02548, "freeCashflow": -7951432, "operatingCashflow": -1710095, "financialCurrency": "USD", "trailingPegRatio": null}]